Search filters

Filters
Clear All

Phase

  • 33
  • 92
  • 1
  • 77
  • 37
  • 1
  • 93
  • 357
  • 158
  • 13
  • 16
  • 328
  • 354
  • 3

Found 357 Neoplasms trials

A listing of Neoplasms medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

18 years - 99 years
All genders
The primary purposes of this research study are to determine the safety and tolerability of dose levels of the investigational drug, XmAb20717, and if XmAb20717 works in treating advanced solid tumors that have progressed after treatment with standard cancer therapies or solid tumors for which there are no appropriate therapies …
 Open Label Study Investigating the Efficacy and Safety of Roxadustat for Treatment of Anemia in Patients Receiving Chemotherapy Treatment for Non-Myeloid Malignancies
18 years - 99 years
All genders
Phase 2
The main purpose of this study is to find out if the experimental drug roxadustat (also known as FG-4592) is safe and effective for potentially treating anemia in people receiving chemotherapy treatments for cancer. 800x600 Normal 0 false false false EN-US X-NONE X-NONE MicrosoftInternetExplorer4 In order to take part in …
 A071701 Genomically-Guided Treatment Trial in Brain Metastases
18 years - 99 years
All genders
Interventional
This phase II trial studies how well genetic testing works in guiding treatment for patients with solid tumors that have spread to the brain. Several genes have been found to be altered or mutated in brain metastases such as NTRK, ROS1, CDK or PI3K. Medications that target these genes such …
 A Phase I/II  Open Label  Multi-center  Non-randomized Dose Escalation and Dose Expansion Study of AMXI-5001 in Patients with Advanced Malignancies
18 years - 99 years
All genders
Phase 1
The purpose of this study is to help define the proper dose amounts, safety and benefits of AMXI-5001 in participants 18 years and older, who have the disease which the study drug may treat, for example, cancer. This study is the first time AMXI-5001 has been given to people. We …
99 years or below
All genders
This is a small scale investigational study to compare different fluorescent camera imaging systems against the current standard (Visionsense VS3 Iridium system) for patients with Ovarian cancer. The VS3 is and FDA approved device currently in phase 3 clinical trials at the University of Pennsylvania and other institutions in combination …
 A Phase 1 Study of the Highly-selective RET
99 years or below
All genders
Phase 1
This is a phase 1 study with Highly-selective RET inhibiter, Blu-667, in patients with Thyroid Cancer, Non-Small cell lung cancer and other advanced solid tumors. The study will be conducted at multiple centers in the United States and Europe. the purpose of this trial is to determine the maximum tolerated …
 ADJUVANT CEMIPLIMAB VERSUS PLACEBO AFTER SURGERY AND RADIATION THERAPY IN PATIENTS WITH HIGH RISK CUTANEOUS SQUAMOUS CELL CARCINOMA
18 years - 99 years
All genders
Purpose is to determine if cemiplimab (given as infusion in the vein) will prevent cutaneous squamous cell cancer from returning after surgery and radiation. Subjects at least 18 years of age who have had surgery and radiation therapy for cutaneous squamous cell cancer, and there is a risk that this …
18 years - 99 years
All genders
Phase 1
Interventional
The research study is being conducted to determine if a same-day intravenous (into a vein) injection of indocyanine green (ICG) detected using an imaging system, can be a useful tool in identifying and differentiating tumor tissue from normal tissues.
 UPCC 24116: A Phase II Pilot Trial of Hydroxychloroquine  Everolimus or the Combination for Prevention of Recurrent Breast Cancer
99 years or below
All genders
Phase 2
The main purpose of this study is to: 1) determine the feasibility of giving hydroxychloroquine, everolimus or the combination to people with disseminated tumor cells detected in their bone marrow. 2) determine how tolerable these drugs are in people who have completed treatment for breast cancer. 3) determine how well …
 Endometrial Cancer Molecularly Targeted Therapy Consortium
18 years - 99 years
Female
The purpose of this study is to confirm that tumor alterations and biomarkers can direct biologic therapies and potentially enhance survival outcomes in women with Endometrial Cancer
231 - 240 of 357